Control of dendritic cell cross-presentation by the major histocompatibility complex class I cytoplasmic domain

Nature Immunology

Volumn 4, Issue 11, 2003, Pages 1065-1073

  Lizée, Gregory ^a   Basha, Genc ^a   Tiong, Jacqueline ^a   Julien, Jean Pierre ^b   Tian, Meimei ^a   Biron, Kaan E ^a   Jefferies, Wilfred A ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; EPITOPE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PEPTIDE; TUMOR ANTIGEN; TYROSINE; VIRUS ANTIGEN;

ANIMAL CELL; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; CELL COMPARTMENTALIZATION; CONTROLLED STUDY; CYTOPLASM; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; ENDOSOME; LYSOSOME; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TARGET CELL; TRANSGENIC MOUSE; VIRUS IMMUNITY;

ANIMALS; CROSS-PRIMING; DENDRITIC CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS I; LYSOSOMES; MICE; MICE, TRANSGENIC; MUTATION; T-LYMPHOCYTES, CYTOTOXIC; TYROSINE;

EID: 0242539823     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/ni989     Document Type: Article

References (50)

1. Banchereau, J. & Steinman, R.M. Dendritic cells and the control of immunity. Nature 392, 245-252 (1998).
2. + T cell responses to infectious agents, tumors, transplants, and vaccines. Adv. Immunol. 73, 1-77 (1999).
3. Heath, W.R. & Carbone, F.R. Cross-presentation, dendritic cells, tolerance and immunity. Annu. Rev. Immunol. 19, 47-64 (2001).
4. Sigal, L.J., Crotty, S., Andino, R. & Rock, K.L. Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen. Nature 398, 77-80 (1999).
5. Svensson, M. & Wick, M.J. Classical class I peptide presentation of a bacterial fusion protein by bone marrow-derived dendritic cells. Eur. J. Immunol. 29, 180-188 (1999).
6. Bevan, M.J. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J. Exp. Med. 143, 1283-1288 (1976).
7. Huang, A.Y. et al. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science 264, 961-965 (1994).
8. Kurts, C. et al. Constitutive class I-restricted exogenous presentation of self antigens in vivo. J. Exp. Med. 184, 923-930 (1996).
9. Kovacsovics-Bankowski, M. & Rock, K.L. A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science 267, 243-246 (1995).
10. Rodriguez, A., Regnault, A., Kleijmeer, M., Ricciardi-Castagnoli, P. & Amigorena, S. Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells. Nat. Cell Biol. 1, 362-368 (1999).
11. Huang, A.Y., Bruce, A.T., Pardoll, D.M. & Levitsky, H.I. In vivo cross-priming of MHC class I-restricted antigens requires the TAP transporter. Immunity 4, 349-355 (1996).
12. Bachmann, M.F. et al. TAP1-independent loading of class I molecules by exogenous viral proteins. Eur. J. Immunol. 25, 1739-1743 (1995).
13. b-restricted peptide presentation. Eur. J. Immunol. 27, 2016-2023 (1997).
14. Liu, T. et al. TAP peptide transporter-independent presentation of heat-killed Sendai virus antigen on MHC class I molecules by splenic antigen-presenting cells. J. Immunol. 159, 5364-5371 (1997).
15. Bakke, O. & Dobberstein, B. MHC class II-associated invariant chain contains a sorting signal for endosomal compartments. Cell 63, 707-716 (1990).
16. Jayawardena-Wolf, J., Benlagha, K., Chiu, Y.H., Mehr, R. & Bendelac, A. CD1d endosomal trafficking is independently regulated by an intrinsic CD1d-encoded tyrosine motif and by the invariant chain. Immunity 15, 897-908 (2001).
17. Jackman, R.M. et al. The tyrosine-containing cytoplasmic tail of CD1b is essential for its efficient presentation of bacterial lipid antigens. Immunity 8, 341-351 (1998).
18. Pathak, S.S. & Blum, J.S. Endocytic recycling is required for the presentation of an exogenous peptide via MHC class II molecules. Traffic 1, 561-569 (2000).
19. Guild, B.C. & Strominger, J.L. Human and murine class I MHC antigens share conserved serine 335, the site of HLA phosphorylation in vivo. J. Biol. Chem. 259, 9235-9240 (1984).
20. d pre-mRNAs results in membrane expression of differentially phosphorylated protein products. EMBO J. 5, 2477-2483 (1986).
21. Vega, M.A. & Strominger, J.L. Constitutive endocytosis of HLA class I antigens requires a specific portion of the intracytoplasmic tail that shares structural features with other endocytosed molecules. Proc. Natl. Acad. Sci. USA 86, 2688-2692 (1989).
22. Zuniga, M.C. et al. Expression and function of transplantation antigens with altered or deleted cytoplasmic domains. Cell 34, 535-544 (1983).
23. Murre, C. et al. Construction, expression and recognition of an H-2 molecule lacking its carboxyl terminus. Nature 307, 432-436 (1984).
24. b does not induce an influenza-specific cytotoxic T lymphocyte response or recycle membrane-bound peptides. Eur. J. Immunol. 25, 1121-1124 (1995).
25. k. J. Immunol. 126, 446-451 (1981).
26. b class I molecule. Cell. Immunol. 160, 33-42 (1995).
27. Liu, T. et al. Heat-inactivated Sendai virus can enter multiple MHC class I processing pathways and generate cytotoxic T lymphocyte responses in vivo. J. Immunol. 154, 3147-3155 (1995).
28. Lutz, M.B. et al. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223, 77-92 (1999).
29. b complex to T cells. J. Immunol. 150, 2724-2736 (1993).
30. Brossart, P. & Bevan, M.J. Presentation of exogenous protein antigens on major histocompatibility complex class I molecules by dendritic cells: pathway of presentation and regulation by cytokines. Blood 90, 1594-1599 (1997).
31. Porgador, A., Yewdell, J.W., Deng, Y., Bennink, J.R. & Germain, R.N. Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody. Immunity 6, 715-726 (1997).
32. + T cells in vivo. J. Immunol. 166, 4355-4362 (2001).
33. MacAry, P.A. et al. Mobilization of MHC class I molecules from late endosomes to the cell surface following activation of CD34-derived human Langerhans cells. Proc. Natl. Acad. Sci. USA 98, 3982-3987 (2001).
34. Heath, W.R. & Carbone, F.R. Cross-presentation in viral immunity and self-tolerance. Nat. Rev. Immunol. 1, 126-134 (2001).
35. Vremec, D., Pooley, J., Hochrein, H., Wu, L. & Shortman, K. CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen. J. Immunol. 164, 2978-2986 (2000).
36. Honing, S., Griffith, J., Geuze, H.J. & Hunziker, W. The tyrosine-based lysosomal targeting signal in lamp-1 mediates sorting into Golgi-derived clathrin-coated vesicles. EMBO J. 15, 5230-5239 (1996).
37. Bonifacino, J.S. & Dell'Angelica, E.C. Molecular bases for the recognition of tyrosine-based sorting signals. J. Cell. Biol. 145, 923-926 (1999).
38. Ohno, H. et al. Interaction of tyrosine-based sorting signals with clathrin-associated proteins. Science 269, 1872-1875 (1995).
39. Owen, D.J. & Evans, P.R. A structural explanation for the recognition of tyrosine-based endocytotic signals. Science 282, 1327-1332 (1998).
40. Park, B. et al. The truncated cytoplasmic tail of HLA-G serves a quality-control function in post-ER compartments. Immunity 15, 213-224 (2001).
41. Ackerman, A.L. & Cresswell, P. Regulation of MHC class I transport in human dendritic cells and the dendritic-like cell line KG-1. J. Immunol. 170, 4178-4188. (2003).
42. Delamarre, L., Holcombe, H. & Mellman, I. Presentation of exogenous antigens on major histocompatibility complex (MHC) class I and MHC class II molecules is differentially regulated during dendritic cell maturation. J. Exp. Med. 198, 111-122 (2003).
43. Goldberg, A.L., Cascio, P., Saric, T. & Rock, K.L. The importance of the proteosome and subsequent proteolytic steps in the generation of antigenic peptides. Mol. Immunol. 39, 147-164 (2002).
44. Ramirez, M.C. & Sigal, L.J. Macrophages and dendritic cells use the cytosolic pathway to rapidly cross-present antigen from live, vaccinia-infected cells. J. Immunol. 169, 6733-6742 (2002).
45. Watts, C. Phagocytosis: how the phagosome became the phag-ER-some. Curr. Biol. 12, R666-668 (2002).
46. Desjardins, M. ER-mediated phagocytosis: a new membrane for new functions. Nat. Rev. Imm. 3, 280-291 (2003).
47. Gagnon, E. et al. Endoplasmic reticulum-mediated phagocytosis is a mechanism of entry into macrophages. Cell 110, 119-131 (2002).
48. Le Gall, S. et al. Nef interacts with the μ subunit of clathrin adaptor complexes and reveals a cryptic sorting signal in MHC I molecules. Immunity 8, 483-495. (1998).
49. + T lymphocytes. AIDS Res. Hum. Retroviruses 17, 1365-1370 (2001).
50. Ho, S.N., Hunt, H.D., Horton, R.M., Pullen, J.K. & Pease, L.R. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77, 51-59 (1989).